A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

Clinical trial NCT05630183 · COMPLETED

Trial details

NCT number: NCT05630183
Sponsor: Agenus Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2023-03-27
Primary completion: 2026-01-05
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.